Enhancing the effectiveness of cognitive tests for diagnosing dementia

NewsGuard 100/100 Score

Cognitive difficulties are a symptom of many neurodegenerative conditions, and the benefits of early and accurate diagnosis are well recognized. It gives patients a better chance to participate actively in planning their care and making legal and financial decisions, while helping them and their families to adjust. At the societal level, appropriate early intervention can reduce health-care costs by delaying care home admission.

However, existing methods are not always reliable in detecting the earliest stages of decline as they typically only take account of test scores, with people scoring above a certain level considered healthy. But well-educated people may score highly and look healthy when they are not, while the less well-educated may perform poorly despite being healthy.

Both scenarios highlight the need to make testing more accurate, particularly as effective new drugs for various neurodegenerative diseases are expected to become available in the near future.

To improve the diagnostic tools, researchers within the EU-funded E-SPACE project, run by Dublin City University, Ireland, reviewed existing cognitive-screening literature. Based on the reviews, they identified two widely used sets of tests that could benefit most from modification using an approach that takes into account aspects other than test scores.

Work with healthy older volunteers helped to determine participants’ responses and behavior during the testing. Based on these findings, changes were made to increase the amount of information that could be collected in a single session. Testing of both healthy and cognitively impaired older adults with the modified versions was then expanded in Ireland, Spain and the United States.

The modified tests are administered in the usual manner, but clinicians now register answers verbatim and examine them in detail. They are being used in two specialist memory clinics in Ireland, with further sites expected to take them up, and have been piloted in the USA. Work on a Spanish version of the tests is ongoing, while the development of a computerized format is also under way.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antipsychotics for dementia associated with elevated risks of serious adverse outcomes